The Latest Ai In The Pbm Industry Statistics Explained
By 2026, the global pharmacy benefit management (PBM) market size is projected to reach USD 1540 billion driven largely by AI applications.
The statistic indicates that by the year 2026, the global pharmacy benefit management (PBM) market is expected to grow substantially, reaching a projected size of USD 1540 billion. This growth is anticipated to be primarily driven by the widespread adoption and implementation of artificial intelligence (AI) applications within the industry. AI technology is projected to revolutionize the way PBMs operate, offering innovative solutions for tasks such as data analysis, decision-making processes, and improving overall efficiency. The significant projected market growth suggests that AI will play a crucial role in shaping the future landscape of pharmacy benefit management on a global scale.
The AI in the healthcare market is projected to grow to $45.2 billion by 2026, with the PBM sector being a significant contributor.
The statistic indicates that the artificial intelligence (AI) market in the healthcare industry is expected to experience substantial growth, reaching a total value of $45.2 billion by the year 2026. This growth is driven by the increasing integration of AI technologies into various healthcare sectors, with Pharmacy Benefit Management (PBM) being highlighted as a significant contributor to this expansion. PBMs play a crucial role in managing drug benefits for patients, and the adoption of AI in this sector is likely to streamline processes, enhance efficiency, and improve patient outcomes. The projected growth underscores the growing importance of AI in transforming healthcare delivery and management practices, with significant implications for the future of the industry.
Roughly 50% of healthcare companies have adopted AI tools in some form, including PBMs.
The statistic suggests that approximately half of healthcare companies, which may include a variety of entities involved in the healthcare industry such as hospitals, insurance providers, and pharmaceutical companies, have integrated artificial intelligence (AI) tools into their operations to some extent. This indicates a growing trend within the healthcare sector towards adopting innovative technologies like AI to improve efficiency, streamline processes, and enhance outcomes. The mention of pharmacy benefit managers (PBMs) specifically highlights that even specialized segments of the healthcare industry are embracing AI, potentially to optimize drug pricing, manage formularies, or enhance patient care through data-driven insights. Overall, the statistic reflects a significant shift towards the incorporation of AI in healthcare practices, signaling an increasing investment in technology-driven solutions to meet the evolving demands of the industry.
The use of Artificial Intelligence in the pharmaceutical industry, which includes the PBM industry, increased by 15% between 2020 and 2021.
The statistic indicates that there was a 15% increase in the utilization of Artificial Intelligence (AI) within the pharmaceutical industry, including the Pharmacy Benefit Management (PBM) sector, from the year 2020 to 2021. This suggests a growing trend towards integrating AI technology to enhance various aspects of drug discovery, development, distribution, and patient care within the industry. The rise in AI adoption could lead to improvements in efficiency, accuracy, and innovation in processes such as drug research, clinical trials, personalized medicine, and medication management. Overall, this growth highlights the industry’s recognition of the potential benefits of AI in optimizing operations and delivering better healthcare outcomes.
About 80% of PBMs are using AI for medication adherence programs.
The statistic “About 80% of PBMs are using AI for medication adherence programs” indicates that the majority of Pharmacy Benefit Managers (PBMs) have incorporated artificial intelligence (AI) technology into their medication adherence initiatives. This suggests a strong trend within the industry towards leveraging advanced technologies to improve patient adherence to prescribed medications. By utilizing AI systems, PBMs can analyze patient data, predict adherence patterns, offer personalized interventions, and ultimately enhance medication adherence rates. The high adoption rate of AI among PBMs highlights a shift towards more data-driven and innovative approaches to healthcare delivery, aiming to optimize patient outcomes and reduce healthcare costs.
With the use of AI, PBM industry is likely to see a 30%-40% decrease in drug-spending for insurers.
The statistic suggests that implementing artificial intelligence (AI) in the pharmacy benefit management (PBM) industry may lead to a significant reduction in drug spending for insurers. Specifically, it is anticipated that AI technologies can help streamline processes, improve efficiency, optimize decision-making, and ultimately lower costs associated with drug purchases and management. The estimated 30%-40% decrease in drug spending implies a substantial potential financial benefit for insurers, signaling the transformative impact that AI can have on cost containment within the PBM sector. This statistic underscores the growing importance of leveraging advanced technologies such as AI to drive innovation and enhance the overall effectiveness of healthcare management systems.
More than 70% of PBMs plan to increase their AI-driven personalized care programs in the next 5 years.
The statistic indicates that over 70% of Pharmacy Benefit Managers (PBMs) are planning to enhance their AI-driven personalized care programs within the next five years. This trend suggests a growing emphasis within the PBM industry on utilizing artificial intelligence technologies to create more tailored and precise healthcare interventions for patients. By leveraging AI algorithms and data analytics, PBMs aim to deliver more individualized care experiences that can improve patient outcomes, reduce costs, and enhance overall quality of care. This statistic highlights the industry’s commitment to innovation and the adoption of advanced technologies to optimize healthcare services in the years ahead.
The use of AI in prescription management, a major part of PBM, is estimated to save consumers up to $100 Billion yearly.
The statistic stating that the use of artificial intelligence (AI) in prescription management, a significant component of pharmacy benefit management (PBM), can potentially save consumers up to $100 billion annually implies that incorporating AI technology in this context leads to substantial cost savings. By leveraging AI algorithms to optimize prescription processing, ensure medication adherence, and identify cost-effective treatment options, PBMs can streamline operations, reduce errors, and lower overall healthcare expenses for consumers. This estimate highlights the transformative impact of AI in enhancing efficiency and driving financial benefits within the prescription management sector, ultimately resulting in significant savings for consumers on an annual basis.
AI applications can potentially improve medication adherence rates by 15% in the PBM industry.
This statistic suggests that the adoption of artificial intelligence (AI) applications in the pharmacy benefit management (PBM) industry has the potential to lead to a 15% increase in medication adherence rates. Medication adherence is a critical factor in healthcare outcomes, and improving adherence rates can result in better patient health and reduced healthcare costs. By leveraging AI technologies, such as predictive analytics and personalized reminders, PBMs can better identify and address adherence barriers, customize interventions, and provide more tailored support to individuals, ultimately resulting in a significant improvement in medication adherence rates within the industry.
AI applications in the global PBM retail pharmacies market is estimated to grow at a CAGR of 4.8% from 2019 to 2025.
This statistic indicates the projected growth rate of artificial intelligence (AI) applications within the global Pharmacy Benefit Management (PBM) retail pharmacies market over the period from 2019 to 2025. The Compound Annual Growth Rate (CAGR) of 4.8% suggests a steady increase in the adoption and utilization of AI technologies in PBM retail pharmacies, which are expected to enhance operational efficiency, patient care, and overall business performance in the industry. This growth rate signifies a positive trend towards integrating AI solutions in pharmacy operations to optimize processes, improve customer service, and stay competitive in the evolving healthcare landscape.
Up to 65% of health plan pharmacy directors believe AI will greatly improve the medication authorization process.
The statistic “Up to 65% of health plan pharmacy directors believe AI will greatly improve the medication authorization process” indicates that a significant portion of pharmacy directors within health plans see the potential benefits of implementing artificial intelligence (AI) in the medication authorization process. This suggests that AI technology is perceived as a promising tool for enhancing efficiency and accuracy in the authorization of medications, which can potentially lead to improved patient care and better operational outcomes within healthcare settings. The high percentage of pharmacy directors expressing belief in the benefits of AI highlights a growing acceptance and recognition of the role that AI can play in streamlining processes and driving innovation in the healthcare industry.
A majority of PBMs (78%) are leveraging AI to reduce outpatient drug costs.
The statistic indicates that 78% of Pharmacy Benefit Managers (PBMs) are utilizing Artificial Intelligence (AI) technology to help minimize outpatient drug expenses. This suggests that a significant portion of PBMs are recognizing the potential of AI in optimizing their operations and strategies for managing drug costs in outpatient settings. By incorporating AI tools, PBMs can analyze data more efficiently, identify cost-saving opportunities, and make more informed decisions to ultimately lower outpatient drug expenses. Overall, the statistic highlights a growing trend within the PBM industry towards leveraging technological advancements like AI to improve cost management practices and enhance overall efficiency.
The use of AI in processing prescription claims, a significant contribution of PBMs, can increase efficiencies by 21%.
The statistic highlights the significant impact of utilizing artificial intelligence (AI) technology in processing prescription claims by pharmacy benefit managers (PBMs). Specifically, the data suggests that implementing AI can lead to a notable increase in efficiencies by 21%. This improvement signifies a substantial enhancement in the speed, accuracy, and overall effectiveness of managing prescription claims, ultimately streamlining processes and potentially reducing costs for both PBMs and healthcare providers. By leveraging AI capabilities in this context, PBMs can harness the power of advanced technologies to optimize operations and provide better services to customers, contributing to more efficient and effective healthcare systems overall.
The application of AI in the PBM industry could help in the detection of drug abuse, potentially improving interventions by up to 65%.
This statistic suggests that implementing artificial intelligence (AI) technology in the Pharmacy Benefit Management (PBM) industry has the potential to significantly enhance the detection of drug abuse by up to 65%. By leveraging AI algorithms and machine learning techniques, PBMs could analyze large volumes of data efficiently and effectively identify patterns indicative of drug abuse or misuse. This enhanced detection capability could lead to more timely interventions and support for individuals struggling with substance abuse, thereby potentially improving intervention outcomes by up to 65%. By harnessing the power of AI, the PBM industry could play a crucial role in addressing the challenges associated with drug abuse and promoting better healthcare outcomes for individuals in need.
Artificial intelligence can help PBMs reduce medication errors, potentially decreasing them by up to 50%.
The statistic suggests that artificial intelligence (AI) can be utilized by pharmacy benefit managers (PBMs) to effectively reduce medication errors by as much as 50%. This indicates that AI technology has the potential to significantly improve the accuracy and safety of medication management processes within the healthcare system. By leveraging AI tools such as machine learning algorithms and automation, PBMs can enhance their ability to identify and prevent errors in prescription processing, drug interactions, dosages, and other critical aspects of medication administration. The substantial reduction in medication errors not only benefits patient health by minimizing the risk of adverse events but also contributes to overall healthcare cost savings and efficiency improvements.
References
0. – https://www.www.managedhealthcareexecutive.com
1. – https://www.www.marketresearchfuture.com
2. – https://www.www.grandviewresearch.com
3. – https://www.www.ncbi.nlm.nih.gov
4. – https://www.www.forbes.com
5. – https://www.www.mckesson.com
6. – https://www.www.mobihealthnews.com
7. – https://www.www.hcinnovationgroup.com
8. – https://www.www2.deloitte.com
9. – https://www.www.healthcarefinancenews.com
10. – https://www.www.beckershospitalreview.com
11. – https://www.www.pharmacytimes.com
